Financial Statements — CLLS
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 59.81 | 149.04 | 84.39 | 129.44 | 248.23 |
| Inventory | -- | -- | -- | -- | 2.47 |
| Total Current Assets | -- | -- | -- | 175.17 | 280.35 |
| Total Non-current Assets | 123.33 | 101.34 | 114.39 | 145.72 | 177.21 |
| Total Assets | 353.97 | 407.15 | 227.67 | 320.88 | 457.57 |
| Total Current Liabilities | 167.43 | 159.63 | 42.05 | 55.28 | 51.45 |
| Total Non-current Liabilities | 89.42 | 98.90 | 89.07 | 85.08 | 103.80 |
| Total Liabilities* | 256.86 | 258.54 | 131.12 | 140.36 | 155.24 |
| Retained Earnings | -- | -- | -- | -- | (586.28) |
| Total Stockholder Equity | 97.11 | 148.61 | 96.56 | 180.52 | 302.32 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 16.73 | 8.06 | 0.18 | 1.35 | 11.18 |
| Research & Development | 23.08 | 23.52 | 22.14 | 29.05 | 31.15 |
| Selling, General & Admin | 5.08 | 3.88 | 3.95 | 8.41 | 9.34 |
| Total Operating Expenses | -- | 26.71 | 25.66 | 36.84 | 52.10 |
| Operating Income | (9.59) | (17.21) | (23.66) | (34.08) | (37.48) |
| Pretax Income | -- | (25.50) | -- | -- | -- |
| Tax Provision | 0.00 | (0.19) | (0.26) | 0.00 | 0.00 |
| Net Income | (23.74) | (25.27) | (13.58) | (19.45) | (41.61) |
| Basic EPS | (0.24) | (0.28) | (0.19) | (0.42) | (0.88) |
| Diluted EPS | (0.24) | (0.28) | (0.19) | (0.42) | (0.88) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (27.47) | 28.87 | (47.37) | (60.18) | (53.05) |
| Investing Cash Flow | (48.49) | (108.48) | (1.56) | (2.54) | 9.94 |
| Financing Cash Flow | (8.36) | 90.41 | 39.60 | 10.31 | 52.63 |
